<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03900546</url>
  </required_header>
  <id_info>
    <org_study_id>PRAM</org_study_id>
    <nct_id>NCT03900546</nct_id>
  </id_info>
  <brief_title>Arterial Tone Influence on Cardiac Output Measured by PRAM</brief_title>
  <official_title>Influence of Arterial Tone Changes on Cardiac Output Measurement by Pressure Recording Analytical Method</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università Politecnica delle Marche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università Politecnica delle Marche</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the role of arterial tone in the accuracy of cardiac output (CO)
      measurement by Pressure Recording Analytical Method (PRAM). Patients receiving noradrenaline
      who need for clinical reason to change the noradrenaline dose will be enrolled. We use
      echocardiography as reference method of CO measurement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pressure Recording Analytical Method (PRAM) is an arterial pulse contour analysis method for
      CO measurement. As it is an uncalibrated method, one possible reason for its inaccuracy is
      rapid changes in arterial tone.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2014</start_date>
  <completion_date type="Actual">February 2020</completion_date>
  <primary_completion_date type="Actual">February 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of cardiac output after variation of noradrenaline dose: ECO versus PRAM</measure>
    <time_frame>Before and 30 minutes after noradrenaline dose variation</time_frame>
    <description>Agreement between echocardiography and PRAM in CO measurement during arterial tone changes induced by different dose of noradrenaline</description>
  </primary_outcome>
  <enrollment type="Actual">31</enrollment>
  <condition>Cardiac Output</condition>
  <condition>Critically Ill</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MostCare</intervention_name>
    <description>CO measurement using echocardiography and PRAM before and after noradrenaline dose change due to clinical reason</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill patients admitted to intensive care unit that need variation of
        noradrenaline dose for clinical reason.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  invasive blood pressure monitoring on site

          -  need to start or change the dose of noradrenaline infusion for clinical reason

        Exclusion Criteria:

          -  age &lt;18

          -  arrhythmia

          -  severe valvular insufficiency

          -  pregnancy

          -  low quality arterial signal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abele Donati, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università Politecnica delle Marche</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Ospedali Riuniti Ancona</name>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 29, 2019</study_first_submitted>
  <study_first_submitted_qc>April 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2019</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università Politecnica delle Marche</investigator_affiliation>
    <investigator_full_name>Abele Donati, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will not be shared with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

